IDH2 and astrocytoma (excluding glioblastoma): A cohort of proneural (RTKI, n = 10) GBMs was used for comparison with the oligodendroglioma cohort and mix of classic and mesenchymal GBMs (n = 10 for each subtype) was used for comparison with IDH mutant astrocytoma.